T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Sea Limited
SE
|
+$1.34B |
| 3 |
Morgan Stanley
MS
|
+$1.23B |
| 4 |
Incyte
INCY
|
+$1.05B |
| 5 |
Ross Stores
ROST
|
+$968M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.05B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.5B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
JPMorgan Chase
JPM
|
+$1.13B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.44% |
| 2 | Healthcare | 17.77% |
| 3 | Consumer Discretionary | 14.38% |
| 4 | Financials | 11.9% |
| 5 | Communication Services | 10.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
NeoGenomics
NEO
$2.08B
| $31.4M | ﹤0.01% |
1,013,614
+74,071
| +8% | +$2.05M |
|
1002
Eagle Materials
EXP
$6.38B
| $31.2M | ﹤0.01% |
443,794
-167,450
| -27% | -$10.5M |
|
1003
Molson Coors Class B
TAP
$7.86B
| $31.1M | ﹤0.01% |
904,467
-1,102,188
| -55% | -$44M |
|
1004
CMS Energy
CMS
$22.2B
| $31M | ﹤0.01% |
530,606
-40,883
| -7% | -$2.37M |
|
|
TRHC
1005
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $30.6M | ﹤0.01% |
558,964
-30,770
| -5% | -$1.76M |
|
|
SPNS
1006
DELISTED
Sapiens International
SPNS
| $30.6M | ﹤0.01% |
1,092,694
+447,970
| +69% | +$11M |
|
|
BWIN
1007
Baldwin Insurance Group
BWIN
$2.94B
| $30.5M | ﹤0.01% |
1,764,873
+1,354,685
| +330% | +$16.4M |
|
1008
Wintrust Financial
WTFC
$11B
| $30.4M | ﹤0.01% |
697,046
-127,213
| -15% | -$5.08M |
|
1009
Labcorp
LH
$26B
| $30.4M | ﹤0.01% |
212,708
-14,374
| -6% | -$1.99M |
|
1010
GoDaddy
GDDY
$12.3B
| $30.3M | ﹤0.01% |
413,660
-1,630
| -0.4% | -$117K |
|
1011
Amcor
AMCR
$21.4B
| $30.1M | ﹤0.01% |
589,557
-63,630
| -10% | -$2.97M |
|
1012
Silgan Holdings
SLGN
$4.42B
| $30.1M | ﹤0.01% |
928,790
+178,975
| +24% | +$5.82M |
|
1013
Hormel Foods
HRL
$13.5B
| $29.9M | ﹤0.01% |
620,033
-72,175
| -10% | -$3.45M |
|
1014
Nektar Therapeutics
NKTR
$2.48B
| $29.9M | ﹤0.01% |
86,093
-7,548
| -8% | -$2.36M |
|
|
HCCI
1015
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $29.8M | ﹤0.01% |
1,704,391
-6,069
| -0.4% | -$102K |
|
1016
Rocket Pharmaceuticals
RCKT
$361M
| $29.5M | ﹤0.01% |
1,409,947
-117,811
| -8% | -$2.12M |
|
1017
Red Robin
RRGB
$181M
| $29.5M | ﹤0.01% |
2,892,993
+438,354
| +18% | +$5.52M |
|
1018
Gaotu Techedu
GOTU
$401M
| $29.5M | ﹤0.01% |
491,563
+2,318
| +0.5% | +$91.8K |
|
|
ORTX
1019
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $29.5M | ﹤0.01% |
491,312
+55,642
| +13% | +$5.1M |
|
1020
CBRE Group
CBRE
$43.8B
| $29.5M | ﹤0.01% |
651,566
-48,012
| -7% | -$2.07M |
|
|
PRA
1021
DELISTED
ProAssurance
PRA
| $29.3M | ﹤0.01% |
2,027,064
+8,611
| +0.4% | +$148K |
|
|
PGRE
1022
DELISTED
Paramount Group
PGRE
| $29.3M | ﹤0.01% |
3,803,627
-1,823,532
| -32% | -$15.4M |
|
1023
Douglas Dynamics
PLOW
$969M
| $29.2M | ﹤0.01% |
830,071
+2,256
| +0.3% | +$78.2K |
|
1024
Restaurant Brands International
QSR
$26.9B
| $29M | ﹤0.01% |
531,636
-18,261
| -3% | -$921K |
|
1025
EPAM Systems
EPAM
$5.17B
| $29M | ﹤0.01% |
115,176
-6,163
| -5% | -$1.36M |
|
Similar funds
T. Rowe Price Associates's Q2 2020 Portfolio in Review
As of Q2 2020, T. Rowe Price Associates held 2,591 positions worth $795B, up 26% from $632B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
T. Rowe Price Associates's Q2 2020 filing shows 79 new, 1,096 increased, 1,255 reduced and 100 closed positions. Its largest new stake was Vroom Inc: 200,362 shares worth $797M. The largest sale was Boeing, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2020 buy was Vroom Inc: 200,362 shares worth $797M.
- T. Rowe Price Associates added most to Microsoft in Q2 2020, an estimated $2B increase.
- T. Rowe Price Associates's biggest Q2 2020 reduction was Boeing, cutting an estimated $2.05B.
- T. Rowe Price Associates fully exited Raytheon Company in Q2 2020, selling an estimated $1.01B.
- T. Rowe Price Associates's ten largest holdings make up 25% of its $795B portfolio in Q2 2020.
- T. Rowe Price Associates opened 79 new positions and closed 100 in Q2 2020.
- T. Rowe Price Associates's portfolio value rose 26% quarter-over-quarter to $795B.
Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.